The recovery peptide elite athletes have been quietly using for a decade. Now available without the gatekeeping — and with a physician designing your protocol.
Peer-reviewed studies on BPC-157 since the 1990s
Standard recovery cycle length in our protocols
Elite-athlete use before this got mainstream
BPC-157 is a synthetic pentadecapeptide derived from a gastric protein. The animal-model literature shows it accelerates tissue repair, reduces inflammation, and supports gut healing. Athletes have been quietly using it for over a decade because it works — and because the rest-of-the-world recovery options are slower, less reliable, and don't address the underlying inflammatory pathways.
We compound it under physician supervision. Your shoulder strain, your tweaked knee, your gut issue that ten doctors couldn't crack — these are exactly what the published research targets.
You have a soft-tissue injury (tendon, ligament, muscle) that's slow to heal. You've tried rest, PT, and time, and it's still there. You're an active person who wants to be active again. You have a GI issue your doctor can't pin down.
You have active cancer or recent cancer history. Pregnancy or breastfeeding. You compete under WADA-tested governance (BPC-157 is on the prohibited list).
Drawn from athlete anecdotal experience and the animal-study literature. Your physician calibrates dose and cycle length to your specific injury.
Subjective swelling and acute pain start to fade. Range of motion begins to return.
Tissue-repair markers measurable in animal models. The slow-healing injury starts feeling like a healing injury.
Most soft-tissue protocols complete here. Return to training conservatively.
Some athletes cycle BPC-157 during high-volume training periods to support recovery.
BPC-157 has been in the recovery toolkit of elite athletes, MMA fighters, and CrossFit competitors for over 10 years. The reason you haven't heard about it is regulatory, not pharmacological. Now you have access to the same protocol, with a physician designing it.
Human safety data is limited; most evidence is from animal models and athlete-anecdotal reports. Side-effect profile is mild but we're upfront about what's incomplete.
Mild headache · Injection-site soreness · Fatigue in first few days · Vivid dreams (anecdotal)
Long-term human safety. Effects in cancer history populations. Interaction with other peptides at high doses. Our physician walks through this honestly.
$140.000 COP / 5mg
2-week supply at 250–500mcg/day · MD intake · Shipping (launch pricing)
$440.000 COP / 2× 10mg
Full 4-week protocol · MD check-in · Priority WhatsApp · Stack options (launch pricing)
BPC-157 is dispensed via magistral compounding under individual physician review. Most evidence is preclinical (animal model); no Phase 3 human trials exist. Currently on the USADA prohibited list for sport. Not for use in active cancer, pregnancy, or breastfeeding. Discuss your medical history with our physician during intake.